PubMed

High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.

Rennstam K, Hedenfalk I.

Breast Cancer Res. 2006;8(4):213. Review.PMID: 16895590 [PubMed - indexed for MEDLINE]Related articlesFree article

Re-evaluating early breast neoplasia.

Moulis S, Sgroi DC.

Breast Cancer Res. 2008;10(1):302. Epub 2008 Feb 8.PMID: 18279539 [PubMed - indexed for MEDLINE]Related articlesFree article

Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer.

Mastracci TL, Boulos FI, Andrulis IL, Lam WL.

Breast Cancer Res. 2007;9(6):215. Review.PMID: 18036272 [PubMed - indexed for MEDLINE]Related articlesFree article

High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.

Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, van Spaendonk R, Wolman SR.

Breast Cancer Res Treat. 2006 Mar;96(2):177-86.PMID: 16319984 [PubMed - indexed for MEDLINE]Related articles

Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.

Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM.

Breast Cancer Res. 2004;6(5):R499-513. Epub 2004 Jul 6. Erratum in: Breast Cancer Res. 2005;7(1):32. PMID: 15318932 [PubMed - indexed for MEDLINE]Related articlesFree article

Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.

Schedin P, Borges V.

Breast Cancer Res. 2009;11(2):102. Epub 2009 Mar 26.PMID: 19344495 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression profiling of the tumor microenvironment during breast cancer progression.

Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.

Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.PMID: 19187537 [PubMed - indexed for MEDLINE]Related articlesFree article

Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.

André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S.

Lancet Oncol. 2009 Apr;10(4):381-90. Epub 2009 Feb 25.PMID: 19249242 [PubMed - indexed for MEDLINE]Related articles

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.PMID: 18928525 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.

Gao Y, Niu Y, Wang X, Wei L, Lu S.

J Mol Med. 2009 Feb;87(2):145-52. Epub 2008 Oct 21.PMID: 18936904 [PubMed - indexed for MEDLINE]Related articles

[Establishing a cytogenetic and morphological progression models of invasive breast cancer. Comparative genomic hybridization (CGH) in malignant and premalignant tumors of the female breast]

Bürger H, Poremba C, Diallo R, Dockhorn-Dworniczak B, Böcker W.

Pathologe. 2000 Sep;21(5):375-82. German. PMID: 11092010 [PubMed - indexed for MEDLINE]Related articles

Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.

Wagner PL, Kitabayashi N, Chen YT, Shin SJ.

Am J Clin Pathol. 2009 Dec;132(6):871-6.PMID: 19926578 [PubMed - indexed for MEDLINE]Related articles

Molecular evolution of breast cancer.

Simpson PT, Reis-Filho JS, Gale T, Lakhani SR.

J Pathol. 2005 Jan;205(2):248-54. Review.PMID: 15641021 [PubMed - indexed for MEDLINE]Related articles

Premalignant and in situ breast disease: biology and clinical implications.

Arpino G, Laucirica R, Elledge RM.

Ann Intern Med. 2005 Sep 20;143(6):446-57.PMID: 16172443 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S.

Oncogene. 2001 Jun 7;20(26):3348-53.PMID: 11423985 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.

Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, Steel M, Streuli C.

Breast Cancer Res. 2008;10(2):R26. Epub 2008 Mar 27. Review.PMID: 18371194 [PubMed - indexed for MEDLINE]Related articlesFree article

Histological and biological evolution of human premalignant breast disease.

Allred DC, Mohsin SK, Fuqua SA.

Endocr Relat Cancer. 2001 Mar;8(1):47-61. Review.PMID: 11350726 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast.

Ding L, Kleer CG.

Cancer Res. 2006 Oct 1;66(19):9352-5.PMID: 17018586 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J.

Cancer Res. 1997 Apr 15;57(8):1597-604.PMID: 9108466 [PubMed - indexed for MEDLINE]Related articlesFree article

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.

Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.

BMC Cancer. 2007 Mar 27;7:55.PMID: 17389037 [PubMed - indexed for MEDLINE]Related articlesFree article